Calendar of Events

Zoom credentials will be shared with registrants closer to the event date.

Join STS-PAC Chair Keith S. Naunheim, MD, and STS Council on Health Policy and Relationships Chair Joseph C. Cleveland Jr., MD, for a conversation about the outcome of the 2024 election and how it will affect cardiothoracic surgeons, their practices, and their patients. 

Discussion topics include: 

The first session of the South Asia webinar series delves into valve repair strategies for rheumatic mitral valve disease. Expert panelists will provide an overview of the current state of rheumatic heart disease in South Asia’s developing countries, along with best practices for case selection tailored to early career surgeons. The webinar will also feature discussions on proven repair techniques for managing rheumatic mitral stenosis and regurgitation.

Moderators

Vinod H. Thourani, MD 
Piedmont Heart Institute
Atlanta, GA 

Early career surgeons should plan to attend this webinar on effective financial management of student loans, presented by an expert speaker from the White Coat Investor. The presentation will examine a variety of student loan considerations:  loan repayment plans (IBR, SAVE, PAYE), loan forgiveness (Public Service Loan Forgiveness), refinancing, and making a personal loan management plan.

In the past five years, immunotherapy has transformed the approach to treating resectable lung cancer in both neoadjuvant and adjuvant settings. During this webinar, experts will explore the continued importance of radiation therapy in managing resectable lung cancer and highlight essential insights that thoracic surgeons need for daily practice.  

Sponsored by AstraZeneca

Moderators

Nathaniel R. Evans III, MD
Thomas Jefferson University
Philadelphia, PA

Circulating tumor DNA (ctDNA) is a blood test that can be used to detect and monitor thoracic malignancies. It is being used to detect mutations, monitor for recurrence after surgery and other treatments, and can even be used in conjunction with screening to help identify malignancy. As the field continues to advance, it is crucial for thoracic surgeons, trainees, and healthcare providers to stay informed about the latest developments in ctDNA testing and its applications for thoracic patients.

Sponsored by AstraZeneca